Loading clinical trials...
Loading clinical trials...
Open Label Exploratory Study to Evaluate the Effect of Dupilumab on Skin Barrier Function in Patients With Moderate to Severe Atopic Dermatitis
Conditions
Interventions
Dupilumab SAR231893
Locations
2
United States
Investigational Site Number 8400001
Denver, Colorado, United States
Investigational Site Number 1240001
Montreal, Canada
Start Date
July 16, 2020
Primary Completion Date
June 17, 2021
Completion Date
June 17, 2021
Last Updated
September 18, 2025
NCT07262983
NCT06389136
NCT06342713
NCT07223697
NCT07290803
NCT07265479
Lead Sponsor
Sanofi
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions